A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To assess the efficacy of dronedarone in preventing cardiovascular hospitalization or death
from any cause in a population of high-risk patients with atrial fibrillation/atrial flutter
(AF/AFL).
To assess that dronedarone is well tolerated in this population.